Emerging Role of mTOR in the Response to Cancer Therapeutics

Trends in Cancer - United States
doi 10.1016/j.trecan.2016.03.008
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Elsevier BV

Related search

Growth Modulatory Role of Zinc in Prostate Cancer and Application to Cancer Therapeutics

International Journal of Molecular Sciences
Organic ChemistryMolecular BiologyTheoretical ChemistryInorganic ChemistryComputer Science ApplicationsSpectroscopyMedicineCatalysisPhysical
2020English

Emerging Therapeutics in Pulmonary Hypertension

American Journal of Physiology - Lung Cellular and Molecular Physiology
PulmonaryRespiratory MedicinePhysiologyCell Biology
2018English

Targeted Therapeutics in SLE: Emerging Strategies to Modulate the Interferon Pathway

Clinical and Translational Immunology
AllergyImmunologyNursing
2016English

Rethinking the Response to Emerging Microbes: Vaccines and Therapeutics in the Ebola Era—a Conference at Harvard Medical School

Journal of Virology
Insect ScienceImmunologyMicrobiologyVirology
2015English

Editorial: Peripheral Immunity in Parkinson's Disease: Emerging Role and Novel Target for Therapeutics

Frontiers in Neurology
Neurology
2019English

The Emerging Role of ESR1 Mutations in Luminal Breast Cancer as a Prognostic and Predictive Biomarker of Response to Endocrine Therapy

Cancers
Cancer ResearchOncology
2019English

New Emerging Targets in Cancer Immunotherapy: The Role of Neoantigens

ESMO Open
Cancer ResearchOncology
2020English

Rapalogs and mTOR Inhibitors as Anti-Aging Therapeutics

Journal of Clinical Investigation
Medicine
2013English

Galectins Control mTOR in Response to Endomembrane Damage

Molecular Cell
Cell BiologyMolecular Biology
2018English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy